Cite

HARVARD Citation

    Ollila, T. et al. (2022). Seroconversion and outcomes after initial and booster COVID‐19 vaccination in adults with hematologic malignancies. Cancer. 128 (18), pp. 3319-3329. [Online]. 
  
Back to record